Scrooged for the Holidays…

Dec. 12, 2007
Sadly, this year will bring bad news, in the form of pink slips, for thousands of U.S. workers in a number of industries, as The Guardian recently reported (Click here for a sobering update).  BMS leads the pharma pack just now.  Local newspapers report that the company's 10% in planned staff reductions will not affect anyone at the company's new biopharma facility in Devens. We sincerely hope that anyone and everyone affected finds new positions as soon as possible.   Our web site has some resources that might be of some, if limited, help.  For anyone who might contact us, we'll share anything we learn about positions that become open willingly and gladly, but it's up to you out there in the industry to accept cold calls and help anyone out there who might inquire at some networking or other event. It's too much to hope for, but nevertheless, here is a hope that, for all companies in all industries, future mergers and acquisitions are made with thought of the possible future human toll firmly in mind. AMS
Sadly, this year will bring bad news, in the form of pink slips, for thousands of U.S. workers in a number of industries, as The Guardian recently reported (Click here for a sobering update).  BMS leads the pharma pack just now.  Local newspapers report that the company's 10% in planned staff reductions will not affect anyone at the company's new biopharma facility in Devens. We sincerely hope that anyone and everyone affected finds new positions as soon as possible.   Our web site has some resources that might be of some, if limited, help.  For anyone who might contact us, we'll share anything we learn about positions that become open willingly and gladly, but it's up to you out there in the industry to accept cold calls and help anyone out there who might inquire at some networking or other event. It's too much to hope for, but nevertheless, here is a hope that, for all companies in all industries, future mergers and acquisitions are made with thought of the possible future human toll firmly in mind. AMS
About the Author

pharmamanufacturing | pharmamanufacturing